Hana Pharm Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.021x

Hana Pharm Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hana Pharm Co Ltd (293480) has a cash flow conversion efficiency ratio of 0.021x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.91 Billion ≈ $4.68 Million USD) by net assets (₩331.75 Billion ≈ $224.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hana Pharm Co Ltd (2016–2025)

Cash flow conversion efficiency of Hana Pharm Co Ltd from 2016 to 2025. This chart illustrates how Hana Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hana Pharm Co Ltd (293480) stock price for real-time trading data and today's change.

Hana Pharm Co Ltd Cash Flow Conversion Ratio Explained

Hana Pharm Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hana Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Pharm Co Ltd ranked by their cash flow conversion efficiency. Also see Hana Pharm Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Amotech Co. Ltd KQ:052710	0.021x
Samick Thk KO:004380	0.064x
Kewaunee Scientific Corporation NASDAQ:KEQU	0.026x
Logistic Properties of the Americas NYSE MKT:LPA	0.009x
Humacyte Inc NASDAQ:HUMA	-8.403x
Yoosung T&S Co. Ltd KQ:024800	0.004x
Taeyang Metal Industrial Co Ltd KO:004105	-0.073x
Accel Solutions Group Ltd TA:ACCL	-0.026x

Annual Cash Flow Conversion Efficiency for Hana Pharm Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Hana Pharm Co Ltd from 2016 to 2025. Review 293480 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩313.41 Billion ≈ $212.39 Million	₩9.18 Billion ≈ $6.22 Million	0.029x	-64.22%
2024-12-31	₩309.18 Billion ≈ $209.52 Million	₩25.30 Billion ≈ $17.14 Million	0.082x	+23.60%
2023-12-31	₩277.98 Billion ≈ $188.39 Million	₩18.40 Billion ≈ $12.47 Million	0.066x	-42.46%
2022-12-31	₩268.40 Billion ≈ $181.89 Million	₩30.88 Billion ≈ $20.93 Million	0.115x	+12.98%
2021-12-31	₩251.90 Billion ≈ $170.71 Million	₩25.66 Billion ≈ $17.39 Million	0.102x	+51.91%
2020-12-31	₩232.38 Billion ≈ $157.48 Million	₩15.58 Billion ≈ $10.56 Million	0.067x	-53.43%
2019-12-31	₩220.33 Billion ≈ $149.32 Million	₩31.72 Billion ≈ $21.49 Million	0.144x	+7.17%
2018-12-31	₩205.39 Billion ≈ $139.19 Million	₩27.59 Billion ≈ $18.70 Million	0.134x	-56.98%
2017-12-31	₩81.30 Billion ≈ $55.09 Million	₩25.38 Billion ≈ $17.20 Million	0.312x	+38.97%
2016-12-31	₩55.48 Billion ≈ $37.60 Million	₩12.46 Billion ≈ $8.45 Million	0.225x	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$97.89 Million

₩144.44 Billion KRW

Market Cap Rank

#19080 Global

#918 in Korea

Share Price

₩8150.00

Change (1 day)

-0.49%

52-Week Range

₩8070.00 - ₩11820.00

All Time High

₩26028.86